❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Cancer Immunology ❭ Immunotherapy against solid cancers [Kyte] ❭ Research projects ❭

Research project overview

ALICE: A randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer 

REPORT: Reirradiation and PD-1 blockade on recurrent squamous cell head and neck tumors

ICON: A randomized phase IIb study evaluating immunogenic chemotherapy combined with double immunological checkpoint blockade in patients with metastatic luminal B breast cancer 

 
Scroll to top

Home Dept. of Cancer Immunology Immunotherapy against solid cancers [Kyte]

  • Group members
  • Research projects
    • Alice
    • REPORT
    • ICON
  • Publications
  • Available positions
  • News and Events

Recent publications

Singh R, Kyte JA (2025)
STEAP1: a promising target in prostate cancer therapy
Trends Cancer (in press)
DOI 10.1016/j.trecan.2025.05.007, PubMed 40527692

Røssevold AH, Tekpli X, Lingjærde OC, Russnes HG, Vallon-Christersson J, Borgen E, Lømo J, Garred Ø, Dorraji E, Kristensen VN, Naume B, Kyte JA (2025)
High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis
Commun Med (Lond), 5 (1), 234
DOI 10.1038/s43856-025-00865-z, PubMed 40523912

Pati NB, Jin Y, Kumar S, Kyte JA, Ciosk R (2025)
Thermal potentiation improves IFN-γ production but not cytotoxicity in human CAR-T cells
BMC Res Notes, 18 (1), 192
DOI 10.1186/s13104-025-07249-5, PubMed 40270044

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)